search
Back to results

The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism (BARIA-DDZ)

Primary Purpose

Obesity, Diabetes Mellitus, Type 2

Status
Recruiting
Phase
Locations
Germany
Study Type
Observational
Intervention
surgery
Sponsored by
German Diabetes Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an observational trial for Obesity focused on measuring weight loss after bariatric surgery, Insulin sensitivity, insulin resistance

Eligibility Criteria

20 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Aged ≥ 20 years- ≤ 70 years
  • BMI 20- 25 kg/m 2 normal- weight group
  • BMI 35- 39,9 kg/m 2 (Obesity grade 2)
  • BMI >40 kg/m 2 (Obesity grade 3)

Exclusion Criteria:

  • Acute illness 2 weeks before start of examination
  • Autoimmune or Immune disorder diseases (Leukozyten < 5000/µl
  • Renal insufficiency (Kreatin > 1,5 mg/dl)
  • Heart disease, condition after heart attack
  • Anemia (Hb <12g/l, controlled before every day of examination) or blood donations 4weeks before examination.
  • Participation in another trial within the last 2 weeks
  • Pharmacological- immunotherapy (Cortisol, Antihistaminika, ASS)
  • Thyroid disorders
  • Glitazone Therapy
  • Pregnancy, Lactation, Menstruation
  • Smoking cigarettes, Alcohol- and drug abuse
  • Psychiatric disorders
  • Risk for/ or diagnosed HIV/ AIDS or Hepatitis B/C
  • Liver disease, which are not caused by non- alcoholic steato- hepatitis
  • Working on night shifts or irregular rhythm of night- day
  • Impaired wound healing or clotting disorders
  • Allergic reaction to local anesthetics
  • Malignant cancer

Sites / Locations

  • DDZ (Deutsches Diabetes Zentrum)Recruiting

Arms of the Study

Arm 1

Arm Type

Arm Label

Surgery

Arm Description

bariatric surgery

Outcomes

Primary Outcome Measures

Energy metabolism
whole body substrate oxidation, ex vivo mitochondrial function via measurement of high resolution respirometry and in vivo mitochondrial function via measurement of ATP production

Secondary Outcome Measures

weight loss
body weight and body composition before and after bariatric surgery
Insulin sensitivity
Whole body glucose uptake and endogenous glucose production as measure of skeletal muscle and hepatic insulin sensitivity

Full Information

First Posted
November 13, 2011
Last Updated
May 10, 2022
Sponsor
German Diabetes Center
Collaborators
Dep.of General-, Visceral- and Pediatric Surgery, HHU, Duesseldorf, Dep.for Metabolic Diseases, HHU, Duesseldorf
search

1. Study Identification

Unique Protocol Identification Number
NCT01477957
Brief Title
The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism
Acronym
BARIA-DDZ
Official Title
Assessment of the Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism
Study Type
Observational

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 2012 (undefined)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
German Diabetes Center
Collaborators
Dep.of General-, Visceral- and Pediatric Surgery, HHU, Duesseldorf, Dep.for Metabolic Diseases, HHU, Duesseldorf

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is: To explore to what extent insulin sensitivity, energy metabolism and ectopic lipid storage can be improved by bariatric surgery To explore to what extent hepatic and muscular disorders of energy metabolism occur in patients with obesity (degree 2-3) To explore whether the steato liver occurring in patients with obesity (degree 2-3) is associated with the degree of liver inflammation
Detailed Description
Insulin resistance strongly relates to ectopic lipid deposition in skeletal muscle and the liver, which correlate with insulin resistance. Lipid metabolites accumulating in skeletal muscle and the liver are thought to impair insulin signalling and thereby reduce glucose uptake and glycogen storage. Insulin resistant humans frequently present with decreased mitochondrial function in skeletal muscle which might contribute to lipid accumulation and the development of insulin resistance. Non-alcoholic liver disease (NAFLD) comprise fatty liver, steatohepatitis and cirrhosis. NAFLD correlate with insulin resistance increased risk for cardiovascular diseases, type 2 diabetes and hepatocellular. The mechanisms leading from fatty liver to steatohepatitis and insulin resistance in the liver are yet unclear. Bariatric surgery relates to surgery for the reduction of body weight. Bariatric surgery frequently leads to normalization of glucose tolerance in previously diabetic humans even before the onset of body weight reduction. The underlying mechanisms are yet unclear. In this study we aim to explore the mechanisms underlying the onset of insulin resistance and steatohepatitis in patients with fatty liver and to identify the mechanisms leading to improved glucose tolerance in humans after bariatric surgery. We test the following hypotheses: increased lipid availability leads to (i) increased lipid oxidation and oxidative stress (ii) accumulation of lipid metabolites that impair insulin signalling (iii) bariatric surgery improves insulin sensitivity by increasing lipid oxidation. This study will contribute to the understanding of NAFLD and will help to identify new targets for the therapy of diabetes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Diabetes Mellitus, Type 2
Keywords
weight loss after bariatric surgery, Insulin sensitivity, insulin resistance

7. Study Design

Enrollment
450 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Surgery
Arm Description
bariatric surgery
Intervention Type
Procedure
Intervention Name(s)
surgery
Other Intervention Name(s)
bariatric surgery
Intervention Description
biliopancreatic diversion, gastric banding, gastric sleeve resection
Primary Outcome Measure Information:
Title
Energy metabolism
Description
whole body substrate oxidation, ex vivo mitochondrial function via measurement of high resolution respirometry and in vivo mitochondrial function via measurement of ATP production
Time Frame
5 years
Secondary Outcome Measure Information:
Title
weight loss
Description
body weight and body composition before and after bariatric surgery
Time Frame
5 years
Title
Insulin sensitivity
Description
Whole body glucose uptake and endogenous glucose production as measure of skeletal muscle and hepatic insulin sensitivity
Time Frame
5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Aged ≥ 20 years- ≤ 70 years BMI 20- 25 kg/m 2 normal- weight group BMI 35- 39,9 kg/m 2 (Obesity grade 2) BMI >40 kg/m 2 (Obesity grade 3) Exclusion Criteria: Acute illness 2 weeks before start of examination Autoimmune or Immune disorder diseases (Leukozyten < 5000/µl Renal insufficiency (Kreatin > 1,5 mg/dl) Heart disease, condition after heart attack Anemia (Hb <12g/l, controlled before every day of examination) or blood donations 4weeks before examination. Participation in another trial within the last 2 weeks Pharmacological- immunotherapy (Cortisol, Antihistaminika, ASS) Thyroid disorders Glitazone Therapy Pregnancy, Lactation, Menstruation Smoking cigarettes, Alcohol- and drug abuse Psychiatric disorders Risk for/ or diagnosed HIV/ AIDS or Hepatitis B/C Liver disease, which are not caused by non- alcoholic steato- hepatitis Working on night shifts or irregular rhythm of night- day Impaired wound healing or clotting disorders Allergic reaction to local anesthetics Malignant cancer
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael Roden, MD
Organizational Affiliation
German Diabetes Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
DDZ (Deutsches Diabetes Zentrum)
City
Düsseldorf
State/Province
NRW
ZIP/Postal Code
40225
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michael Roden, MD
Phone
49(0) 2 11-33 82-201
Email
michael.roden@ddz.de
First Name & Middle Initial & Last Name & Degree
Sabine Kahl, MD
Phone
0211/3382-698
Email
sabine.kahl@ddz.de

12. IPD Sharing Statement

Citations:
PubMed Identifier
25955209
Citation
Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, Herder C, Carstensen M, Krausch M, Knoefel WT, Schlensak M, Roden M. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 2015 May 5;21(5):739-46. doi: 10.1016/j.cmet.2015.04.004.
Results Reference
result
PubMed Identifier
35988689
Citation
Pafili K, Kahl S, Mastrototaro L, Strassburger K, Pesta D, Herder C, Putzer J, Dewidar B, Hendlinger M, Granata C, Saatmann N, Yavas A, Gancheva S, Heilmann G, Esposito I, Schlensak M, Roden M. Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease. J Hepatol. 2022 Dec;77(6):1504-1514. doi: 10.1016/j.jhep.2022.08.010. Epub 2022 Aug 19.
Results Reference
derived
PubMed Identifier
29602794
Citation
Apostolopoulou M, Gordillo R, Koliaki C, Gancheva S, Jelenik T, De Filippo E, Herder C, Markgraf D, Jankowiak F, Esposito I, Schlensak M, Scherer PE, Roden M. Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis. Diabetes Care. 2018 Jun;41(6):1235-1243. doi: 10.2337/dc17-1318. Epub 2018 Mar 30.
Results Reference
derived
Links:
URL
https://ddz.de/studien/baria-ddz-studie/
Description
Homepage

Learn more about this trial

The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism

We'll reach out to this number within 24 hrs